FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy
Related Topics >> ADHD | Shire

FDA blesses Shire's latest ADHD med

Tools

Shire got the FDA nod for childhood and adolescent use of its extended-release drug Intuniv, the first selective alpha-2A receptor agonist for treatment of ADHD. Report


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FiercePharma Email Newsletter:

More stories about ADHD   Shire